SCHEMBL13773255

SCHEMBL13773255

NS(=O)(=O)OC[C@H]1O[C@@H](n2ccc3ccccc32)[C@H](O)[C@@H]1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ CA4 P22748 1/20 0.51
▸ CA9 Q16790 1/20 0.51
▸ ATG7 O95352 12/20 0.45
▸ P2RY2 P41231 1/20 0.45
▸ P2RY4 P51582 1/20 0.45
▸ UBA6 A0AVT1 1/20 0.45
▸ UBA7 P41226 1/20 0.45
▸ NAE1 Q13564 1/20 0.45
▸ UBA3 Q8TBC4 1/20 0.45
▸ SAE1 Q9UBE0 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ TRPM2 O94759 1/20 0.44
▸ LMNA P02545 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ MTOR P42345 1/20 0.43
▸ MDM2 Q00987 1/20 0.43
▸ NCOA1 Q15788 1/20 0.43
▸ NCOA3 Q9Y6Q9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13773250 0.82 TRPM2 (0.62) TRPM2
SCHEMBL23982553 0.80 LMNA (0.56) LMNATHRBMTORMDM2NCOA1
SCHEMBL20419148 0.80 LMNA (0.56) LMNATHRBMTORMDM2NCOA1
SCHEMBL2981353 0.80 LMNA (0.56) LMNATHRBMTORMDM2NCOA1
SCHEMBL4141706 0.80 LMNA (0.56) LMNATHRBMTORMDM2NCOA1
SCHEMBL219357 0.79 LMNA (0.54) LMNATHRBMTORMDM2NCOA1
SCHEMBL30186598 0.79 LMNA (0.54) LMNATHRBMTORMDM2NCOA1
SCHEMBL25100657 0.79 LMNA (0.54) LMNATHRBMTORMDM2NCOA1
SCHEMBL155587 0.79 LMNA (0.54) LMNATHRBMTORMDM2NCOA1
SCHEMBL30186595 0.79 LMNA (0.54) LMNATHRBMTORMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946188-B2 Anti-microbial agents and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2015-02-03 — — US disclosed
US-8946188-B2 Anti-microbial agents and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2015-02-03 — — US disclosed
US-20140024611-A1 ANTI-MICROBIAL AGENTS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2014-01-23 — — US disclosed
US-20140024611-A1 ANTI-MICROBIAL AGENTS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2014-01-23 — — US disclosed
US-8461128-B2 Anti-microbial agents and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2013-06-11 — — US disclosed
US-8461128-B2 Anti-microbial agents and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2013-06-11 — — US disclosed
US-20090170805-A1 ANTI-MICROBIAL AGENTS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140024611-A1 ANTI-MICROBIAL AGENTS AND USES THEREOF ACAT1, ACAT2, APEH CA1 4226/4885CA2 2174/4885CA4 3206/4885
US-20090170805-A1 ANTI-MICROBIAL AGENTS AND USES THEREOF ACAT1, ACAT2, APEH CA1 4226/4885CA2 2174/4885CA4 3206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback